Voting results and Scrutinizers Report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Ltd held its 30th Annual General Meeting on September 30, 2025, via Video Conference from 9:30 a.m. to 9:54 a.m. A total of 9 resolutions were put to vote and all were passed with overwhelming shareholder support — over 99.99% in favor on each resolution. The resolutions included adoption of audited financial statements, re-appointment of directors (Mr. S. Nagi Reddy as Chairman & MD, Mr. S. Koni Reddy and Mr. S. Manoj Kumar Reddy as Wholetime Directors), appointment of Mr. Satyam Reddy Gopidi as a Non-Executive Independent Director, approval of related party transactions for FY 2025-26, ratification of cost auditor remuneration, and appointment of PSK & Associates as secretarial auditors. The promoter group (54,39,204 shares) voted 100% in favor on all resolutions. Public shareholder participation was very low — only 8,912 out of 45,60,796 public shares (0.1954%) were polled.
This is a routine procedural disclosure — all standard AGM business was cleared without any pushback from shareholders. No major strategic shift or capital event was announced. The very low public voting turnout (0.2%) is a notable governance flag, though all items passed comfortably.